Target Name: OR13G1
NCBI ID: G441933
Review Report on OR13G1 Target / Biomarker Content of Review Report on OR13G1 Target / Biomarker
OR13G1
Other Name(s): O13G1_HUMAN | Olfactory receptor family 13 subfamily G member 1 | olfactory receptor OR1-37 | olfactory receptor family 13 subfamily G member 1 | OR1-37 | Olfactory receptor OR1-37 | Olfactory receptor 13G1

OR13G1: A Promising Drug Target for Cancer and Neurodegenerative Disorders

OR13G1 (O13G1_HUMAN) is a protein that is expressed in various tissues of the human body, including the brain, heart, liver, and muscle. It is a member of the OR13 family of transmembrane proteins, which are characterized by the presence of a protein transmembrane domain and a cytoplasmic tail. OR13G1 is unique among its family members because it is a glycophospholipid-rich protein, which means it is covered in lipids and has a phospholipid profile.

OR13G1 has been identified as a potential drug target in several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its unique structure and location in the body make it an attractive target for drug developers because it is expected to be expressed in a variety of tissues and cells, which could make it more difficult to target. However, its location in the cell membrane and its rich lipid content also make it a more stable target for drugs that can interact with its phospholipid profile.

One of the reasons OR13G1 is considered a promising drug target is its role in several disease processes that are currently treated with drugs that have limited efficacy. For example, OR13G1 has been shown to be involved in the development and progression of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease. Studies have also shown that OR13G1 is involved in the development of cancer, including breast and ovarian cancer.

In addition to its potential role in disease, OR13G1 is also a valuable biomarker for several types of cancer. Its expression has been shown to be associated with the development and progression of several types of cancer, including breast, ovarian, and prostate cancer. This makes it a promising target for cancer diagnostics and therapies.

OR13G1 is also a good candidate for a drug that can target OR13G1 specifically, rather than its downstream effects. OR13G1 has a unique structure that makes it difficult to predict its behavior, but studies have shown that it is sensitive to a variety of drugs, including small molecules, peptides, and antibodies. This makes it a promising target for drug developers who are looking for a specific and potent drug that can interact with its unique biology.

In conclusion, OR13G1 (O13G1_HUMAN) is a protein that is expressed in various tissues of the human body and is considered a potential drug target for several diseases, including cancer and neurodegenerative disorders. Its unique structure and location in the body make it a more stable target for drugs that can interact with its phospholipid profile, and its expression in multiple tissues makes it a valuable biomarker for cancer diagnostics and therapies. Further research is needed to fully understand its biology and develop effective drugs that can target OR13G1 specifically.

Protein Name: Olfactory Receptor Family 13 Subfamily G Member 1

Functions: Odorant receptor

The "OR13G1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OR13G1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

OR13H1 | OR13J1 | OR13Z2P | OR14A16 | OR14A2 | OR14C36 | OR14I1 | OR14J1 | OR14L1P | OR1A1 | OR1A2 | OR1B1 | OR1C1 | OR1D2 | OR1D4 | OR1D5 | OR1E1 | OR1E2 | OR1E3 | OR1F1 | OR1F2P | OR1G1 | OR1I1 | OR1J1 | OR1J2 | OR1J4 | OR1K1 | OR1L1 | OR1L3 | OR1L4 | OR1L6 | OR1L8 | OR1M1 | OR1N1 | OR1N2 | OR1P1 | OR1Q1 | OR1S1 | OR1S2 | OR2A1 | OR2A1-AS1 | OR2A12 | OR2A14 | OR2A2 | OR2A20P | OR2A25 | OR2A4 | OR2A42 | OR2A7 | OR2A9P | OR2AE1 | OR2AG1 | OR2AG2 | OR2AJ1 | OR2AK2 | OR2AL1P | OR2AM1P | OR2AP1 | OR2AT4 | OR2B11 | OR2B2 | OR2B3 | OR2B6 | OR2C1 | OR2C3 | OR2D2 | OR2D3 | OR2F1 | OR2F2 | OR2G2 | OR2G3 | OR2G6 | OR2H1 | OR2H2 | OR2I1P | OR2J1 | OR2J2 | OR2J3 | OR2J4P | OR2K2 | OR2L13 | OR2L1P | OR2L2 | OR2L3 | OR2L5 | OR2L8 | OR2L9P | OR2M1P | OR2M2 | OR2M3 | OR2M4 | OR2M5 | OR2M7 | OR2Q1P | OR2S2 | OR2T1 | OR2T10 | OR2T11 | OR2T12 | OR2T2